Plasma PCSK9 levels are significantly modified by statins and fibrates in humans
Plasma PCSK9 levels are significantly modified by statins and fibrates in humans
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Proprotein convertase subtilisin kexin-like 9 (PCSK9) is a secreted glycoprotein that is transcriptionally regulated by cholesterol status. It modulates levels of circulating low density lipoprotein cholesterol (LDLC) by negatively regulating low density lipoprotein receptor (LDLR) levels. PCSK9 variants that result in 'gain of function' have been...
Alternative Titles
Full title
Plasma PCSK9 levels are significantly modified by statins and fibrates in humans
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_9ce75fd86af74c82871b363170d90ab9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ce75fd86af74c82871b363170d90ab9
Other Identifiers
ISSN
1476-511X
E-ISSN
1476-511X
DOI
10.1186/1476-511X-7-22
